Determination of 9α, 11β-prostaglandin F2 in human urine. Combination of solid-phase extraction and radioimmunoassay

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 65, Issue 5-6, 2001, Pages 271-280

  Mucha, I ^a   Riutta, A ^b  

^a Institute of Isotopes   (Hungary)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; DIAGNOSTIC AGENT; DRUG DERIVATIVE; NICOTINIC ACID; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 METHYL ESTER; RADIOACTIVE IODINE;

ADULT; ARTICLE; CHROMATOGRAPHY; DIAGNOSTIC TEST; DRUG DETERMINATION; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; CLINICAL CHEMISTRY; EVALUATION; FEMALE; IMMUNOLOGY; METABOLISM; METHODOLOGY; REFERENCE VALUE; URINE;

ORYCTOLAGUS CUNICULUS;

ADULT; CHEMISTRY, CLINICAL; DINOPROST; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; NIACIN; RADIOIMMUNOASSAY; REFERENCE VALUES;

EID: 0035544828     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0325     Document Type: Article

References (45)

1. 2): A unique biologically active prostaglandin produced enzymatically in vivo in humans
2. 2 in a normal human male volunteer
3. 2, that inhibits platelet aggregation and constricts blood vessels
4. 2): Formation and metabolism by human lung and contractile effects on human bronchial smooth muscle
5. 2, is a potent contractile agonist of human and guinea pig airways
6. 2 in patients with systemic mastocytosis
7. 2 in a human female with mastocytosis
8. 2 after inhalation or intravenous infusion in normal man
9. 2 by an active NADPH-dependent 11-ketoreductase
10. 2 by stereospecific antibody in various rat tissues
11. 2
12. 2 11-ketoreductase, contribution of prostaglandin F synthetase and its cellular localization
13. 2 and its subsequent metabolism in rat, rabbit and guinea pig
14. 2
15. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction
16. Evidence for mast cell activation during exercise-induced bronchoconstriction
17. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions
18. 2 in human urine and plasma by gas chromatography-mass spectrometry
19. Aspirin idiosyncrasy in systemic mast cell desease: A new look at mediator release during aspirin desenzitization
20. GC/MS analysis of urinary excretion of 9 alpha, 11 beta-PGF(2) in acute and exercise-induced asthma in children
21. Allergen-stimulated release of mediators into sheep bronchoalveolar fluid. Effect of cyclooxygenase inhibition
22. Profile of prostanoid release following antigen challenge in vivo in the skin of man
23. 2
24. 2 in the circulation: Demonstration of elevated levels in patients with disorders of systemic mast cell activation
25. 2 in vivo in humans following the administration of nicotinic acid
26. 2 release following oral administration of niacin in humans
27. Tolerance to nicotinic acid flushing
28. 2 metabolites in biological fluids
29. 2: A family of icosanoids produced in vivo in humans
30. 2 by stable isotope dilution mass spectrometric assay
31. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids
32. 2 by a stable isotope dilution mass spectrometric assay
33. 2 metabolites in urine: Comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry
34. Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers
35. 125I-labeled radioligands
36. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica
37. 2
38. 2: A biochemical perspective
39. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay
40. 125I-labeled ligand: Albumin and heterogeneous immunoreactivity
41. 2 for reliable determination with radioimmunoassay
42. 1α for determination with radioimmunoassay
43. Effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man